Raymond James & Associates’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,133
Closed -$403K 3978
2022
Q4
$403K Sell
12,133
-6,875
-36% -$228K ﹤0.01% 3014
2022
Q3
$599K Buy
19,008
+6,414
+51% +$202K ﹤0.01% 2733
2022
Q2
$383K Buy
12,594
+1,097
+10% +$33.4K ﹤0.01% 3056
2022
Q1
$298K Sell
11,497
-471
-4% -$12.2K ﹤0.01% 3391
2021
Q4
$244K Sell
11,968
-11,198
-48% -$228K ﹤0.01% 3548
2021
Q3
$446K Sell
23,166
-54,163
-70% -$1.04M ﹤0.01% 3135
2021
Q2
$1.72M Sell
77,329
-12,059
-13% -$267K ﹤0.01% 2205
2021
Q1
$2.35M Sell
89,388
-6,465
-7% -$170K ﹤0.01% 1908
2020
Q4
$1.79M Buy
95,853
+5,367
+6% +$100K ﹤0.01% 1951
2020
Q3
$1.54M Sell
90,486
-19,106
-17% -$324K ﹤0.01% 1917
2020
Q2
$2.55M Buy
109,592
+12,736
+13% +$297K ﹤0.01% 1575
2020
Q1
$814K Buy
+96,856
New +$814K ﹤0.01% 2116
2015
Q4
Sell
-14,167
Closed -$242K 2409
2015
Q3
$242K Buy
+14,167
New +$242K ﹤0.01% 2191
2013
Q3
Sell
-30,096
Closed -$647K 1990
2013
Q2
$647K Buy
+30,096
New +$647K 0.01% 1375